Summarised prevalence of HMX alerts over all intravenous infusions, DERS infusions and bed days
| Clinical area | HMX events | Total infusions | Total DERS infusions (% from total infusions) | HMX per 1000 DERS administration (95% CI) | HMX per 1000 administration (95% CI) | HMX per 1000 bed days |
| Paediatric | 665 | 29 560 | 11 847 (40.1) | 56.1 (52.1 to 60.4) | 22.5 (20.9 to 24.3) | |
| Medical | 2423 | 197 535 | 82 769 (41.9) | 29.3 (28.1 to 30.4) | 12.3 (11.8 to 12.8) | |
| Surgical | 1303 | 137 095 | 67 916 (49.5) | 19.2 (18.2 to 20.2) | 9.5 (9 to 10) | |
| Women’s care | 89 | 15 161 | 5274 (34.8) | 16.9 (13.7 to 20.7) | 5.9 (4.8 to 7.2) | |
| Theatres | 8 | 2712 | 979 (36.1) | 8.2 (4.1 to 16) | 2.9 (1.5 to 5.8) | |
| Critical care | 1579 | 363 07 | 169 478 (46.7) | 9.3 (8.9 to 9.8) | 4.3 (4.1 to 4.6) | |
| Total | 6067 | 745 170 | 338 263 (45.4) | 17.9 (17.5 to 18.4) | 8.1 (7.9 to 8.3) | 9.4 (9.2 to 9.7) |
Bed days are presented using total aggregate data only and not subdivided into specialities due to differences in hospital reporting and classification.
DERS, drug error reduction software; HMX, hard maximum.